Senti Biosciences (SNTI) Other Non Operating Income (2021 - 2025)
Senti Biosciences' quarterly Other Non Operating Income came in at $200000.0 in Q4 2025, down 2.91% year-on-year from $206000.0 in Q4 2024, and down 10.31% quarter-over-quarter from $223000.0 in Q3 2025.
Senti Biosciences has reported Other Non Operating Income for 5 years, with the latest figure at $200000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income fell 2.91% year-over-year to $200000.0; the trailing twelve-month figure through Dec 2025 stood at $801000.0 (up 298.51% YoY), and the FY2025 full-year result was $800000.0, up 300.0% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $200000.0, down from $223000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $1.3 million in Q4 2022, with the low at -$54000.0 in Q1 2022.
- Average Other Non Operating Income over 5 years is $133529.4, with a median of $6000.0 recorded in 2024.
- Year-over-year, Other Non Operating Income jumped 13270.0% in 2022 and plunged 800.0% in 2023.
- Tracing SNTI's Other Non Operating Income over 5 years: stood at -$10000.0 in 2021, then jumped by 13270.0% to $1.3 million in 2022, then sank by 100.53% to -$7000.0 in 2023, then jumped by 3042.86% to $206000.0 in 2024, then retreated by 2.91% to $200000.0 in 2025.
- The last three Other Non Operating Income figures came in at $200000.0 (Q4 2025), $223000.0 (Q3 2025), and $200000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 223,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | 206,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | -54,000.00 |
| Dec 31, 2021 | -10,000.00 |
| Sep 30, 2021 | 21,000.00 |